Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
1(100.0%)
1Total
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials
NCT07553481Not Yet Recruiting

Chemotherapy-Induced Hearing Loss and Health Inequality

Role: collaborator

NCT06291142Completed

Early Diagnosis of SSc in the General Rheumatology Clinic - Pilot

Role: collaborator

NCT03861130Unknown

Genetic Determinants of Kawasaki Disease

Role: collaborator

NCT03446092Not ApplicableCompleted

Mindfulness for People With Incurable Cancer

Role: collaborator

NCT03663062Completed

ObeSity Related Colorectal Adenoma Risk

Role: collaborator

NCT03231007Completed

Saving Babies' Lives Project Impact and Results Evaluation: a Mixed Methodology Study

Role: collaborator

NCT03418103Unknown

System to Avoid Fall Events

Role: collaborator

All 7 trials loaded